Picture of Corline Biomedical AB logo

CLBIO — Corline Biomedical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Corline Biomedical Q2 operating loss widens to SEK 2.0 mln

Aug 23 (Reuters) - CORLINE BIOMEDICAL AB  CLBIO.ST  
    * Q2 NET SALES SEK  103,000 VERSUS SEK 367,000 YEAR AGO 
    * Q2 OPERATING LOSS SEK 2.0  MILLION VERSUS LOSS SEK 601,000 
YEAR AGO 
 
Source text for Eikon:  ID:nGNE33wqKY  
Further company coverage:  CLBIO.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Corline Biomedical AB

See all news